News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
462,228 Results
Type
Article (25290)
Company Profile (142)
Press Release (436796)
Section
Business (136230)
Career Advice (1582)
Deals (23549)
Drug Delivery (57)
Drug Development (50291)
Employer Resources (115)
FDA (11749)
Job Trends (10124)
News (225245)
Policy (18536)
Tag
Academia (2052)
Alliances (40330)
Alzheimer's disease (830)
Approvals (11742)
Artificial intelligence (219)
Bankruptcy (166)
Best Places to Work (8497)
Biotechnology (100)
Breast cancer (151)
Cancer (1154)
Career advice (1302)
CAR-T (105)
Cell therapy (276)
Clinical research (40534)
Collaboration (573)
Compensation (103)
COVID-19 (1877)
C-suite (121)
Data (1143)
Diabetes (133)
Diagnostics (5448)
Earnings (46052)
Employer resources (102)
Events (63839)
Executive appointments (416)
FDA (12390)
Funding (484)
Gene therapy (187)
GLP-1 (389)
Government (2303)
Healthcare (13373)
Infectious disease (1967)
Interviews (271)
IPO (10074)
Job creations (1975)
Job search strategy (1092)
Layoffs (181)
Legal (3847)
Lung cancer (151)
Manufacturing (177)
Medical device (12107)
Medtech (12112)
Mergers & acquisitions (13784)
Metabolic disorders (327)
Neuroscience (1089)
NextGen: Class of 2025 (4741)
Non-profit (2804)
Northern California (1247)
Obesity (154)
Opinion (125)
Patents (124)
People (40862)
Phase I (12217)
Phase II (17783)
Phase III (13948)
Pipeline (478)
Postmarket research (1489)
Preclinical (5175)
Radiopharmaceuticals (189)
Rare diseases (195)
Real estate (4105)
Regulatory (13429)
Research institute (1841)
Resumes & cover letters (315)
Series A (99)
Southern California (1226)
Startups (2937)
United States (12199)
Vaccines (471)
Weight loss (93)
Date
Last 7 days (509)
Last 30 days (1657)
Last 365 days (22866)
2025 (3477)
2024 (23593)
2023 (27565)
2022 (37267)
2021 (39991)
2020 (38226)
2019 (33866)
2018 (25602)
2017 (23710)
2016 (22787)
2015 (26493)
2014 (19446)
2013 (16049)
2012 (17384)
2011 (18075)
2010 (16113)
Location
Africa (527)
Arizona (132)
Asia (29844)
Australia (5302)
California (3055)
Canada (1134)
China (263)
Colorado (156)
Connecticut (158)
Europe (66308)
Florida (471)
Georgia (140)
Illinois (306)
Indiana (181)
Japan (105)
Maryland (489)
Massachusetts (2170)
Michigan (186)
Minnesota (257)
New Jersey (959)
New York (967)
North Carolina (561)
Northern California (1247)
Ohio (110)
Pennsylvania (651)
South America (768)
Southern California (1226)
Texas (429)
Utah (98)
Washington State (358)
462,228 Results for "umbra applied technologies group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
UAT Group Subsidiary, Ossifix Orthopedics Begins Comparative Study
Umbra Applied Technologies Group, Inc. announce that its subsidiary, Ossifix Orthopedics has begun a comparative study with doctors across six different sites.
January 20, 2023
·
4 min read
Business
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG).
September 5, 2023
·
1 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
Press Releases
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
July 25, 2024
·
5 min read
Executive Appointments
After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug
Following a 90% drop in share price due to an FDA rejection and a warning letter over Applied Therapeutics’ conduct during a clinical trial, the biotech’s CEO has stepped aside.
December 23, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
January 7, 2025
·
5 min read
BioMidwest
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.
August 2, 2022
·
4 min read
BioMidwest
UAT Group Subsidiary, Ossifix Orthopedics, Launching Demineralized Bone Matrix Product
Umbra Applied Technologies Group, Inc. announced that its subsidiary Ossifix Orthopedics has added a new product to its expanding suite of orthopedic products.
July 19, 2022
·
4 min read
1 of 46,223
Next
